Yarbrough Capital’s Veracyte VCYT Stock Holding History

Yarbrough Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,796	Closed	-$250K	–	211
2023 Q2	$250K	Hold	9,796	–	–	0.01%	190
2023 Q1	$218K	Hold	9,796	–	–	0.02%	188
2022 Q4	$232K	Buy	+9,796	New	+$228K	0.02%	162
2022 Q2	–	Sell	-11,837	Closed	-$326K	–	212
2022 Q1	$326K	Buy	11,837 +2,041	+21%	+$58.4K	0.02%	182
2021 Q4	$404K	Buy	+9,796	New	+$433K	0.02%	156

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Yarbrough Capital's VCYT Position: Q3 2023 in Review

Yarbrough Capital sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 9,796 shares — an estimated $250K sold.

Yarbrough Capital first reported a position in VCYT in Q4 2021 and held it in 5 quarters. The position peaked at $404K in Q4 2021. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

Yarbrough Capital reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
Yarbrough Capital sold 9,796 Veracyte shares in Q3 2023, an estimated $250K.
Yarbrough Capital first reported a position in Veracyte in Q4 2021 and held it in 5 quarters.
Yarbrough Capital's Veracyte position peaked at $404K in Q4 2021.
236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Yarbrough Capital's 13F filing for Q3 2023, filed 12 Oct 2023.